Magaldrate
From Wikipedia, the free encyclopedia
|
Magaldrate
|
|
| Systematic (IUPAC) name | |
| Magnesium aluminate monohydrate | |
| Identifiers | |
| CAS number | |
| ATC code | A02 A02AF01 |
| PubChem | |
| Chemical data | |
| Formula | H3O2- |
| Mol. mass | 86.3092 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Negligible |
| Metabolism | Nil |
| Half life | ? |
| Excretion | Fecal and renal |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status |
OTC |
| Routes | Oral |
Magaldrate (INN), is a common antiacid drug that is used for the treatment of duodenal and gastric ulcers, esophagitis from gastroesophageal reflux.
Contents |
[edit] Formula
Al5Mg10(OH)31(SO4)2 H2O
[edit] Available forms
Magaldrate is available in the form of oral suspension or tablets.
[edit] Interactions and adverse reactions
Magaldrate may negatively influence drugs like tetracyclines, benzodiazepines, and indomethacin. High doses or prolonged usage may lead to an increment of defecation and a reduction in feces consistence. In some cases it can alter the functionality of the gastrointestinal tract, occasionally provoking constipation or diarrhea.
[edit] Brand names
The drug is sold with the following brand names:
- Gradal (Italy);
- Magaltop (Italy);
- Magralibi (Italy);
- Riopan (Argentina, Austria, Brazil, Germany, Italy, belgium).

